www.fdanews.com/articles/180557-fda-awards-marketing-clearance-to-centric-medicals-metatarsal-hemi-implant-system
FDA Awards Marketing Clearance to Centric Medical’s Metatarsal Hemi Implant System
February 15, 2017
Centric Medical, a division of Life Spine, has achieved FDA marketing clearance for its metatarsal hemi implant system.
The device is for use in the treatment of patients with degenerative and post-traumatic arthritis in the metatarsal joint in the presence of good bone stock and for other conditions affecting the metatarsal/phalangeal joint.
The device is a single-use implant intended to be used with or without bone cement. — Cynthia Jessup